AHCO
AdaptHealth Corp.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.07
P/S
0.58
EV/EBITDA
7.09
DCF Value
$26.24
FCF Yield
13.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
6.5%
Operating Margin
7.8%
Net Margin
-2.6%
ROE
-4.6%
ROA
-4.3%
ROIC
6.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $846.3M | $-102.8M | $-0.73 |
| FY 2025 | $3.24B | $-70.8M | $-0.52 |
| Q3 2025 | $820.3M | $22.5M | $0.16 |
| Q2 2025 | $591.8M | $14.7M | $0.10 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.50
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.